BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kornum BR, Knudsen S, Ollila HM, Pizza F, Jennum PJ, Dauvilliers Y, Overeem S. Narcolepsy. Nat Rev Dis Primers 2017;3:16100. [PMID: 28179647 DOI: 10.1038/nrdp.2016.100] [Cited by in Crossref: 109] [Cited by in F6Publishing: 90] [Article Influence: 21.8] [Reference Citation Analysis]
Number Citing Articles
1 Barateau L, Pizza F, Plazzi G, Dauvilliers Y. 50th anniversary of the ESRS in 2022-JSR special issue. J Sleep Res 2022;:e13631. [PMID: 35624073 DOI: 10.1111/jsr.13631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Giannoccaro MP, Sallemi G, Liguori R, Plazzi G, Pizza F. Immunotherapy in Narcolepsy. Curr Treat Options Neurol 2020;22:2. [PMID: 31997035 DOI: 10.1007/s11940-020-0609-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Capittini C, De Silvestri A, Terzaghi M, Scotti V, Rebuffi C, Pasi A, Manni R, Martinetti M, Tinelli C. Correlation between HLA-DQB1*06:02 and narcolepsy with and without cataplexy: approving a safe and sensitive genetic test in four major ethnic groups. A systematic meta-analysis. Sleep Medicine 2018;52:150-7. [DOI: 10.1016/j.sleep.2018.08.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
4 Dauvilliers Y, Barateau L, Lopez R, Rassu AL, Chenini S, Beziat S, Jaussent I. Narcolepsy Severity Scale: a reliable tool assessing symptom severity and consequences. Sleep 2020;43:zsaa009. [DOI: 10.1093/sleep/zsaa009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
5 Choi Y, Raymer BK. Sleep modulating agents. Bioorg Med Chem Lett 2019;29:2025-33. [PMID: 31307886 DOI: 10.1016/j.bmcl.2019.06.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Nordstrand SEH, Juvodden HT, Viste R, Rootwelt T, Karlsen T, Thorsby PM, Swanson D, Nilsen KB, Hansen BH, Knudsen-heier S. Obesity and other medical comorbidities among NT1 patients after the Norwegian H1N1 influenza epidemic and vaccination campaign. Sleep 2020;43:zsz277. [DOI: 10.1093/sleep/zsz277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
7 Heiss JE, Yamanaka A, Kilduff TS. Parallel Arousal Pathways in the Lateral Hypothalamus. eNeuro 2018;5:ENEURO. [PMID: 30225361 DOI: 10.1523/ENEURO.0228-18.2018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Juvodden HT, Alnæs D, Lund MJ, Agartz I, Andreassen OA, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S. Widespread white matter changes in post-H1N1 patients with narcolepsy type 1 and first-degree relatives. Sleep 2018;41. [DOI: 10.1093/sleep/zsy145] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
9 Vetter V, Denizer G, Friedland LR, Krishnan J, Shapiro M. Understanding modern-day vaccines: what you need to know. Annals of Medicine 2018;50:110-20. [DOI: 10.1080/07853890.2017.1407035] [Cited by in Crossref: 90] [Cited by in F6Publishing: 71] [Article Influence: 18.0] [Reference Citation Analysis]
10 Manolis TA, Manolis AA, Apostolopoulos EJ, Melita H, Manolis AS. Cardiovascular Complications of Sleep Disorders: A Better Night's Sleep for a Healthier Heart / From Bench to Bedside. Curr Vasc Pharmacol 2021;19:210-32. [PMID: 32209044 DOI: 10.2174/1570161118666200325102411] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Bakhtadze S, Lim M, Craiu D, Cazacu C. Vaccination in acute immune-mediated/inflammatory disorders of the central nervous system. Eur J Paediatr Neurol 2021;34:118-22. [PMID: 34487956 DOI: 10.1016/j.ejpn.2021.07.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Plazzi G, Clawges HM, Owens JA. Clinical Characteristics and Burden of Illness in Pediatric Patients with Narcolepsy. Pediatric Neurology 2018;85:21-32. [DOI: 10.1016/j.pediatrneurol.2018.06.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
13 Chang ET, Lin CL, Chen SF, Shen YC. Risk of Burn Injury in Patients With Narcolepsy: A Nationwide Population-Based Cohort Study. J Burn Care Res 2020;41:663-7. [PMID: 31927592 DOI: 10.1093/jbcr/iraa004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Quaedackers L, Droogleever Fortuyn H, Van Gilst M, Lappenschaar M, Overeem S. Dissociative Symptoms are Highly Prevalent in Adults with Narcolepsy Type 1. Behav Sleep Med 2021;:1-11. [PMID: 33594925 DOI: 10.1080/15402002.2021.1888729] [Reference Citation Analysis]
15 Pimentel Filho LH, Gomes ACD, Frange C, Tufik S, Coelho FMS. Validation of the Brazilian Portuguese version of the narcolepsy severity scale. Sleep Med 2020;76:134-9. [PMID: 33166827 DOI: 10.1016/j.sleep.2020.10.016] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Baiardi S, Pizza F, Polischi B, Moresco M, Abu-Rumeileh S, Plazzi G, Parchi P. Cerebrospinal fluid biomarkers of neurodegeneration in narcolepsy type 1. Sleep 2020;43:zsz215. [PMID: 31552425 DOI: 10.1093/sleep/zsz215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Löffler P. Review: Vaccine Myth-Buster - Cleaning Up With Prejudices and Dangerous Misinformation. Front Immunol 2021;12:663280. [PMID: 34177902 DOI: 10.3389/fimmu.2021.663280] [Reference Citation Analysis]
18 Cremaschi RC, Hirotsu C, Tufik S, Coelho FM. The sensory pain of Dante's Inferno - Semantics of chronic pain in patients with narcolepsy. Sleep Sci 2019;12:49-52. [PMID: 31105895 DOI: 10.5935/1984-0063.20190055] [Reference Citation Analysis]
19 Järvelä M, Raatikainen V, Kotila A, Kananen J, Korhonen V, Uddin LQ, Ansakorpi H, Kiviniemi V. Lag Analysis of Fast fMRI Reveals Delayed Information Flow Between the Default Mode and Other Networks in Narcolepsy. Cereb Cortex Commun 2020;1:tgaa073. [PMID: 34296133 DOI: 10.1093/texcom/tgaa073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Harwell V, Fasinu PS. Pitolisant and Other Histamine-3 Receptor Antagonists-An Update on Therapeutic Potentials and Clinical Prospects. Medicines (Basel) 2020;7:E55. [PMID: 32882898 DOI: 10.3390/medicines7090055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Pizza F, Barateau L, Dauvilliers Y, Plazzi G. The orexin story, sleep and sleep disturbances. J Sleep Res 2022;:e13665. [PMID: 35698789 DOI: 10.1111/jsr.13665] [Reference Citation Analysis]
22 Johansson K, Wasling P, Axelsson M. Fatigue, insomnia and daytime sleepiness in multiple sclerosis versus narcolepsy. Acta Neurol Scand 2021;144:566-75. [PMID: 34278566 DOI: 10.1111/ane.13497] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Kim H, Cho JW. Narcolepsy, How do We Manage it? J Sleep Med 2020;17:1-10. [DOI: 10.13078/jsm.200006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
24 Scheer D, Schwartz SW, Parr M, Zgibor J, Sanchez-Anguiano A, Rajaram L. Prevalence and incidence of narcolepsy in a US health care claims database, 2008-2010. Sleep 2019;42:zsz091. [PMID: 31004158 DOI: 10.1093/sleep/zsz091] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
25 Muñoz-Lopetegi A, Graus F, Dalmau J, Santamaria J. Sleep disorders in autoimmune encephalitis. Lancet Neurol 2020;19:1010-22. [PMID: 33212053 DOI: 10.1016/S1474-4422(20)30341-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
26 Sivam S, Chamula K, Swieca J, Frenkel S, Saini B. Narcolepsy management in Australia: time to wake up. Med J Aust 2021;215:62-63.e1. [PMID: 34145573 DOI: 10.5694/mja2.51150] [Reference Citation Analysis]
27 Dauvilliers Y, Evangelista E, de Verbizier D, Barateau L, Peigneux P. [18F]Fludeoxyglucose-Positron Emission Tomography Evidence for Cerebral Hypermetabolism in the Awake State in Narcolepsy and Idiopathic Hypersomnia. Front Neurol 2017;8:350. [PMID: 28775709 DOI: 10.3389/fneur.2017.00350] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
28 van der Sluiszen NNJJM, Urbanus B, Lammers GJ, Overeem S, Ramaekers JG, Vermeeren A. On-the-road driving performance of patients with central disorders of hypersomnolence. Traffic Inj Prev 2021;22:120-6. [PMID: 33543997 DOI: 10.1080/15389588.2020.1862804] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Vandi S, Pizza F, Antelmi E, Neccia G, Iloti M, Mazzoni A, Avoni P, Plazzi G. A standardized test to document cataplexy. Sleep Medicine 2019;53:197-204. [DOI: 10.1016/j.sleep.2017.08.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
30 Holm A, Possovre ML, Bandarabadi M, Moseholm KF, Justinussen JL, Bozic I, Lemcke R, Arribat Y, Amati F, Silahtaroglu A, Juventin M, Adamantidis A, Tafti M, Kornum BR. The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio. Proc Natl Acad Sci U S A 2022;119:e2112225119. [PMID: 35452310 DOI: 10.1073/pnas.2112225119] [Reference Citation Analysis]
31 Scarpelli S, Alfonsi V, D'Anselmo A, Gorgoni M, Musetti A, Plazzi G, De Gennaro L, Franceschini C. Dream Activity in Narcoleptic Patients During the COVID-19 Lockdown in Italy. Front Psychol 2021;12:681569. [PMID: 34122276 DOI: 10.3389/fpsyg.2021.681569] [Reference Citation Analysis]
32 Yüceer H, Gezen Ak D, Benbir Şenel G, Dursun E, Yılmaz V, Karadeniz D, Tüzün E, Küçükali Cİ. Classical complement pathway factor alterations in narcolepsy. Acta Neuropsychiatr 2022;:1-8. [PMID: 35034679 DOI: 10.1017/neu.2021.42] [Reference Citation Analysis]
33 Stephansen JB, Olesen AN, Olsen M, Ambati A, Leary EB, Moore HE, Carrillo O, Lin L, Han F, Yan H, Sun YL, Dauvilliers Y, Scholz S, Barateau L, Hogl B, Stefani A, Hong SC, Kim TW, Pizza F, Plazzi G, Vandi S, Antelmi E, Perrin D, Kuna ST, Schweitzer PK, Kushida C, Peppard PE, Sorensen HBD, Jennum P, Mignot E. Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy. Nat Commun 2018;9:5229. [PMID: 30523329 DOI: 10.1038/s41467-018-07229-3] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 19.5] [Reference Citation Analysis]
34 Sarfraz N, Okuampa D, Hansen H, Alvarez M, Cornett EM, Kakazu J, Kaye AM, Kaye AD. pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy. Health Psychology Research 2022;10. [DOI: 10.52965/001c.34222] [Reference Citation Analysis]
35 Kornum BR. Narcolepsy type 1: what have we learned from immunology? Sleep 2020;43:zsaa055. [DOI: 10.1093/sleep/zsaa055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
36 Sauvet F, Erblang M, Gomez-Merino D, Rabat A, Guillard M, Dubourdieu D, Lefloch H, Drogou C, Van Beers P, Bougard C, Bourrrilhon C, Arnal P, Rein W, Mouthon F, Brunner-Ferber F, Leger D, Dauvilliers Y, Chennaoui M, Charvériat M. Efficacy of THN102 (a combination of modafinil and flecainide) on vigilance and cognition during 40-hour total sleep deprivation in healthy subjects: Glial connexins as a therapeutic target. Br J Clin Pharmacol 2019;85:2623-33. [PMID: 31419329 DOI: 10.1111/bcp.14098] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
37 Vandi S, Rodolfi S, Pizza F, Moresco M, Antelmi E, Ferri R, Mignot E, Plazzi G, Silvani A. Cardiovascular autonomic dysfunction, altered sleep architecture, and muscle overactivity during nocturnal sleep in pediatric patients with narcolepsy type 1. Sleep 2019;42:zsz169. [DOI: 10.1093/sleep/zsz169] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
38 Barateau L, Liblau R, Peyron C, Dauvilliers Y. Narcolepsy Type 1 as an Autoimmune Disorder: Evidence, and Implications for Pharmacological Treatment. CNS Drugs 2017;31:821-34. [DOI: 10.1007/s40263-017-0464-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
39 Wigren HK, Porkka-Heiskanen T. Novel concepts in sleep regulation. Acta Physiol (Oxf) 2018;222:e13017. [PMID: 29253320 DOI: 10.1111/apha.13017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
40 Barateau L, Lopez R, Chenini S, Rassu AL, Mouhli L, Dhalluin C, Jaussent I, Dauvilliers Y. Linking clinical complaints and objective measures of disrupted nighttime sleep in narcolepsy type 1. Sleep 2022;45:zsac054. [PMID: 35275598 DOI: 10.1093/sleep/zsac054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
41 Kushida CA, Shapiro CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, Rosenberg R, Roy A, Seiden D, Dubow J, Dauvilliers Y. Once-Nightly Sodium Oxybate (FT218) Demonstrated Improvement of Symptoms in a Phase 3 Randomized Clinical Trial in Patients With Narcolepsy. Sleep 2021:zsab200. [PMID: 34358324 DOI: 10.1093/sleep/zsab200] [Reference Citation Analysis]
42 Dauvilliers Y, Shapiro C, Mayer G, Lammers GJ, Emsellem H, Plazzi G, Chen D, Carter LP, Lee L, Black J, Thorpy MJ. Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial. CNS Drugs 2020;34:773-84. [PMID: 32588401 DOI: 10.1007/s40263-020-00744-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
43 Silvani A. Exploration of autonomic activity in narcolepsy: The riddle remains unsolved. Clinical Neurophysiology 2019;130:406-7. [DOI: 10.1016/j.clinph.2018.12.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
44 [DOI: 10.1101/2021.02.20.432093] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Chaiard J, Weaver TE. Update on Research and Practices in Major Sleep Disorders: Part II-Insomnia, Willis-Ekbom Disease (Restless Leg Syndrome), and Narcolepsy. J Nurs Scholarsh 2019;51:624-33. [PMID: 31524329 DOI: 10.1111/jnu.12515] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
46 Jennum P, Ibsen R, Kjellberg J. Welfare consequences for people diagnosed with nonepileptic seizures: A matched nationwide study in Denmark. Epilepsy Behav 2019;98:59-65. [PMID: 31299534 DOI: 10.1016/j.yebeh.2019.06.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
47 Quaedackers L, van Gilst MM, van Mierlo P, Lammers GJ, Dhondt K, Amesz P, Peeters E, Hendriks D, Vandenbussche N, Pillen S, Overeem S. Impaired social functioning in children with narcolepsy. Sleep 2019;42. [PMID: 30476304 DOI: 10.1093/sleep/zsy228] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
48 Falup-Pecurariu C, Diaconu Ş. Sleep Dysfunction in Parkinson's Disease. Int Rev Neurobiol 2017;133:719-42. [PMID: 28802939 DOI: 10.1016/bs.irn.2017.05.033] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
49 Dauvilliers Y, Bogan RK, Šonka K, Partinen M, Foldvary-schaefer N, Thorpy MJ. Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy. NSS 2022;Volume 14:531-46. [DOI: 10.2147/nss.s279345] [Reference Citation Analysis]
50 Mohammadi S, Dolatshahi M, Zare-shahabadi A, Rahmani F. Untangling narcolepsy and diabetes: Pathomechanisms with eyes on therapeutic options. Brain Research 2019;1718:212-22. [DOI: 10.1016/j.brainres.2019.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
51 Kornum BR, Jennum P. The case for narcolepsy as an autoimmune disease. Expert Review of Clinical Immunology 2020;16:231-3. [DOI: 10.1080/1744666x.2020.1719832] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Li SB, Nevárez N, Giardino WJ, de Lecea L. Optical probing of orexin/hypocretin receptor antagonists. Sleep 2018;41. [PMID: 30060151 DOI: 10.1093/sleep/zsy141] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
53 Ollila HM. Narcolepsy type 1: what have we learned from genetics? Sleep 2020;43:zsaa099. [PMID: 32442260 DOI: 10.1093/sleep/zsaa099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
54 Barateau L, Lopez R, Chenini S, Pesenti C, Rassu AL, Jaussent I, Dauvilliers Y. Depression and suicidal thoughts in untreated and treated narcolepsy: Systematic analysis. Neurology 2020;95:e2755-68. [PMID: 32963102 DOI: 10.1212/WNL.0000000000010737] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
55 Juvodden HT, Viken MK, Nordstrand SEH, Viste R, Westlye LT, Thorsby PM, Lie BA, Knudsen-heier S. HLA and sleep parameter associations in post-H1N1 narcolepsy type 1 patients and first-degree relatives. Sleep 2020;43:zsz239. [DOI: 10.1093/sleep/zsz239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
56 Sahni AS, Carlucci M, Malik M, Prasad B. Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects. Nat Sci Sleep 2019;11:241-52. [PMID: 31695533 DOI: 10.2147/NSS.S218402] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
57 Krahn LE, Zee PC, Thorpy MJ. Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know. Adv Ther 2022;39:221-43. [PMID: 34894325 DOI: 10.1007/s12325-021-01992-4] [Reference Citation Analysis]
58 Quaedackers L, Pillen S, Overeem S. Recognizing the Symptom Spectrum of Narcolepsy to Improve Timely Diagnosis: A Narrative Review. Nat Sci Sleep 2021;13:1083-96. [PMID: 34262379 DOI: 10.2147/NSS.S278046] [Reference Citation Analysis]
59 Filardi M, Demir N, Pizza F, Vandi S, Antelmi E, Noce S, Bruni O, Plazzi G. Prevalence and neurophysiological correlates of sleep disordered breathing in pediatric type 1 narcolepsy. Sleep Medicine 2020;65:8-12. [DOI: 10.1016/j.sleep.2019.07.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
60 Li C, Xie L, Shang S, Dong X, Zhang J, Gao Y, Han F. The Impact of Symptom Severity on Health-Related Quality of Life in People with Narcolepsy Type 1. Behavioral Sleep Medicine. [DOI: 10.1080/15402002.2022.2025805] [Reference Citation Analysis]
61 Overeem S, van Litsenburg RRL, Reading PJ. Sleep disorders and the hypothalamus. Handb Clin Neurol 2021;182:369-85. [PMID: 34266606 DOI: 10.1016/B978-0-12-819973-2.00025-3] [Reference Citation Analysis]
62 Brink-Kjaer A, Christensen JAE, Cesari M, Mignot E, Sorensen HBD, Jennum P. Cortical arousal frequency is increased in narcolepsy type 1. Sleep 2021;44:zsaa255. [PMID: 33249455 DOI: 10.1093/sleep/zsaa255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
63 Raggi A, Plazzi G, Ferri R. Health-Related Quality of Life in Patients With Narcolepsy: A Review of the Literature. J Nerv Ment Dis 2019;207:84-99. [DOI: 10.1097/nmd.0000000000000918] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
64 Lind A, Marzinotto I, Brigatti C, Ramelius A, Piemonti L, Lampasona V. A/H1N1 hemagglutinin antibodies show comparable affinity in vaccine-related Narcolepsy type 1 and control and are unlikely to contribute to pathogenesis. Sci Rep 2021;11:4063. [PMID: 33603024 DOI: 10.1038/s41598-021-83543-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
65 Vellieux G, Frija-Masson J, Rouvel-Tallec A, Drouot X, d'Ortho MP. Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report. Nat Sci Sleep 2021;13:1669-73. [PMID: 34594143 DOI: 10.2147/NSS.S311283] [Reference Citation Analysis]
66 Berro LF, Moreira-Junior EDC, Rowlett JK. The dual orexin receptor antagonist almorexant blocks the sleep-disrupting and daytime stimulant effects of methamphetamine in rhesus monkeys. Drug Alcohol Depend 2021;227:108930. [PMID: 34358767 DOI: 10.1016/j.drugalcdep.2021.108930] [Reference Citation Analysis]
67 Juvodden HT, Alnæs D, Lund MJ, Dietrichs E, Thorsby PM, Westlye LT, Knudsen S. Hypocretin-deficient narcolepsy patients have abnormal brain activation during humor processing. Sleep 2019;42:zsz082. [DOI: 10.1093/sleep/zsz082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
68 Thorpy MJ. Recently Approved and Upcoming Treatments for Narcolepsy. CNS Drugs 2020;34:9-27. [PMID: 31953791 DOI: 10.1007/s40263-019-00689-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 21.0] [Reference Citation Analysis]
69 Lopez R, Micoulaud-Franchi JA, Camodeca L, Gachet M, Jaussent I, Dauvilliers Y. Association of Inattention, Hyperactivity, and Hypersomnolence in Two Clinic-Based Adult Cohorts. J Atten Disord 2020;24:555-64. [PMID: 29771183 DOI: 10.1177/1087054718775826] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
70 Keenan RJ, Oberrauch S, Bron R, Nowell CJ, Challis LM, Hoyer D, Jacobson LH. Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510. J Alzheimers Dis 2021;79:693-708. [PMID: 33361602 DOI: 10.3233/JAD-201177] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Hopkins K, Mukherjee S, Ponce D, Mangum J, Jacobson LH, Hoyer D. Development of a LC-ESI-MRM method for the absolute quantification of orexin A in the CSF of individual mice. Medicine in Drug Discovery 2021;11:100102. [DOI: 10.1016/j.medidd.2021.100102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Jennum PJ, Plazzi G, Silvani A, Surkin LA, Dauvilliers Y. Cardiovascular disorders in narcolepsy: Review of associations and determinants. Sleep Med Rev 2021;58:101440. [PMID: 33582582 DOI: 10.1016/j.smrv.2021.101440] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Olesen AN, Cesari M, Christensen JAE, Sorensen HBD, Mignot E, Jennum P. A comparative study of methods for automatic detection of rapid eye movement abnormal muscular activity in narcolepsy. Sleep Medicine 2018;44:97-105. [DOI: 10.1016/j.sleep.2017.11.1141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
74 Huang B, Xu T, Wang Z, Chen K, Zhang J, Zhao Z, Zhuang J, Wu H. The clinical characteristics of cataplectic attack in narcolepsy type 1. Sleep Med 2021;77:261-9. [PMID: 31607435 DOI: 10.1016/j.sleep.2019.03.015] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
75 Dauvilliers Y, Arnulf I, Szakacs Z, Leu-Semenescu S, Lecomte I, Scart-Gres C, Lecomte JM, Schwartz JC; HARMONY III study group. Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study. Sleep 2019;42:zsz174. [PMID: 31529094 DOI: 10.1093/sleep/zsz174] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 14.5] [Reference Citation Analysis]
76 Nordstrand SEH, Hansen BH, Rootwelt T, Karlsen T, Swanson D, Nilsen KB, Knudsen S. Psychiatric symptoms in patients with post-H1N1 narcolepsy type 1 in Norway. Sleep 2019;42. [DOI: 10.1093/sleep/zsz008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
77 Seiden D, Tyler C, Dubow J. Pharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy Adults. Clin Ther 2021;43:672.e1-672.e14. [PMID: 33632533 DOI: 10.1016/j.clinthera.2021.01.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Pizza F, Barateau L, Jaussent I, Vandi S, Antelmi E, Mignot E, Dauvilliers Y, Plazzi G; for the MonBo Study Group. Validation of Multiple Sleep Latency Test for the diagnosis of pediatric narcolepsy type 1. Neurology 2019;93:e1034-44. [DOI: 10.1212/wnl.0000000000008094] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 5.7] [Reference Citation Analysis]
79 Heyat MBB, Lai D, Akhtar F, Hayat MAB, Azad S, Azad S, Azad S. Bruxism Detection Using Single‐Channel C4‐A1 on Human Sleep S2 Stage Recording. In: Gupta D, Bhattacharyya S, Khanna A, Sagar K, editors. Intelligent Data Analysis. Wiley; 2020. pp. 347-67. [DOI: 10.1002/9781119544487.ch17] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
80 Pizza F, Filardi M, Moresco M, Antelmi E, Vandi S, Neccia G, Mazzoni A, Plazzi G. Excessive daytime sleepiness in narcolepsy and central nervous system hypersomnias. Sleep Breath 2020;24:605-14. [DOI: 10.1007/s11325-019-01867-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
81 Franco P, Dauvilliers Y, Inocente CO, Guyon A, Villanueva C, Raverot V, Plancoulaine S, Lin JS. Impaired histaminergic neurotransmission in children with narcolepsy type 1. CNS Neurosci Ther 2019;25:386-95. [PMID: 30225986 DOI: 10.1111/cns.13057] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
82 Jennum P, Ibsen R, Kjellberg J. Long-term health and socioeconomic consequences of childhood and adolescent-onset of narcolepsy. Sleep Medicine 2020;67:23-7. [DOI: 10.1016/j.sleep.2019.10.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
83 Quaedackers L, De Wit J, Pillen S, Van Gilst M, Batalas N, Lammers GJ, Markopoulos P, Overeem S. A Mobile App for Longterm Monitoring of Narcolepsy Symptoms: Design, Development, and Evaluation. JMIR Mhealth Uhealth 2020;8:e14939. [PMID: 31909723 DOI: 10.2196/14939] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
84 Nordstrand SH, Hansen BH, Kamaleri Y, Nilsen KB, Rootwelt T, Karlsen T, Knudsen S. Changes in quality of life in individuals with narcolepsy type 1 after the H1N1-influenza epidemic and vaccination campaign in Norway: a two-year prospective cohort study. Sleep Medicine 2018;50:175-80. [DOI: 10.1016/j.sleep.2018.05.037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
85 Nguyen XH, Dauvilliers Y, Quériault C, Perals C, Romieu-Mourez R, Paulet PE, Bernard-Valnet R, Fazilleau N, Liblau R. Circulating follicular helper T cells exhibit reduced ICOS expression and impaired function in narcolepsy type 1 patients. J Autoimmun 2018;94:134-42. [PMID: 30104107 DOI: 10.1016/j.jaut.2018.07.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
86 Thorpy MJ, Bogan RK. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Med 2020;68:97-109. [PMID: 32032921 DOI: 10.1016/j.sleep.2019.09.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
87 Kornum BR. Narcolepsy Type I as an autoimmune disorder. Handb Clin Neurol 2021;181:161-72. [PMID: 34238455 DOI: 10.1016/B978-0-12-820683-6.00012-9] [Reference Citation Analysis]
88 Chang ET, Lin CL, Chen SF, Hsu CY, Shen YC. Risk of bone fractures in patients with narcolepsy: a nationwide population-based cohort study. Sleep Med 2020;70:55-9. [PMID: 32197225 DOI: 10.1016/j.sleep.2020.02.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
89 Akpa B, Lee K. Update on Novel Medications to Treat Narcolepsy. Curr Sleep Medicine Rep 2020;6:189-97. [DOI: 10.1007/s40675-020-00178-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Janssens KAM, Quaedackers L, Lammers GJ, Amesz P, van Mierlo P, Aarts L, Peeters E, Hendriks D, Vandenbussche N, Overeem S, Pillen S. Effect of treatment on cognitive and attention problems in children with narcolepsy type 1. Sleep 2020;43:zsaa114. [PMID: 32505131 DOI: 10.1093/sleep/zsaa114] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Kachooei-Mohaghegh-Yaghoobi L, Rezaei-Rad F, Sadeghniiat-Haghighi K, Zamani M. The impact of the HLA DQB1 gene and amino acids on the development of narcolepsy. Int J Neurosci 2020;:1-8. [PMID: 33045884 DOI: 10.1080/00207454.2020.1835903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Lecomte A, Barateau L, Pereira P, Paulin L, Auvinen P, Scheperjans F, Dauvilliers Y. Gut microbiota composition is associated with narcolepsy type 1. Neurol Neuroimmunol Neuroinflamm 2020;7:e896. [PMID: 33037102 DOI: 10.1212/NXI.0000000000000896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
93 Pavkovic IM, Kothare SV. Pharmacologic Approaches to Insomnia and Other Sleep Disorders in Children. Curr Treat Options Neurol. [DOI: 10.1007/s11940-022-00712-9] [Reference Citation Analysis]
94 Moresco M, Lecciso M, Ocadlikova D, Filardi M, Melzi S, Kornum BR, Antelmi E, Pizza F, Mignot E, Curti A, Plazzi G. Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease. Sleep Medicine 2018;44:53-60. [DOI: 10.1016/j.sleep.2017.11.1150] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]